Equities

Vilin Bio Med Ltd

VILINBIO:NSI

Vilin Bio Med Ltd

Actions
  • Price (INR)18.05
  • Today's Change0.00 / 0.00%
  • Shares traded16.00k
  • 1 Year change-21.35%
  • Beta--
Data delayed at least 15 minutes, as of Sep 18 2024 10:21 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2022202220212020
ASSETS
Cash And Short Term Investments0.390.470.67
Total Receivables, Net868981
Total Inventory232121
Prepaid expenses------
Other current assets, total9.199.5016
Total current assets119120118
Property, plant & equipment, net161921
Goodwill, net------
Intangibles, net000
Long term investments000
Note receivable - long term0.490.490.49
Other long term assets0.0000.00
Total assets136139140
LIABILITIES
Accounts payable6.418.1719
Accrued expenses------
Notes payable/short-term debt000
Current portion long-term debt/capital leases464545
Other current liabilities, total1.631.393.13
Total current liabilities545567
Total long term debt7.34100
Total debt535545
Deferred income tax0.580.570.57
Minority interest------
Other liabilities, total00.000
Total liabilities626568
SHAREHOLDERS EQUITY
Common stock333333
Additional paid-in capital------
Retained earnings (accumulated deficit)414139
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity747472
Total liabilities & shareholders' equity136139140
Total common shares outstanding141414
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.